Lilly Launches Axiron In Germany


Acrux' Axiron (testosterone metered-dose lotion) has been launched in Germany by the company's marketing partner, Eli Lilly, as a testosterone replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone.

Axiron is now available in the US, Canada, Australia, Brazil and Germany. Acrux' technology, used in marketed products including Axiron and Evamist (oestradiol metered-dose transdermal spray), is based on a fast-drying, small volume, accurately dosed solution, containing penetration enhancers that when applied topically, deposit drug through the skin for long acting delivery.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare, Medical Devices
Geography: Germany, Australia, United States